The increased scrutiny that comes with direct accountability to equity and debt capital markets, will require Pharmed to establish its credibility as a separately listed company, based on reliable disclosure and guidance on strategic and financial performance and, ultimately, delivering on it.
Pharmed’s leadership demonstrates integrated thinking, through defensible decisions that harmonise the legitimate interests of stakeholders and align to the six capitals model for sustainable value creation. Deepening the company’s reputation as an ethical and responsible corporate citizen that responds adequately to the risks and opportunities in the “triple context” (social, economic and environmental).
A well-constituted and diverse board, with expertise and experience relevant to strategy and the operating context within which Pharmed operates, will be maintained and its independence and oversight of multinational operations, underpinned by a strong governance and control processes, support strategic delivery and the corporate reputation.
Retention and succession planning for the highly experienced, long-serving management team are critical to the continuous leadership development aligned to strategy, diversity and culture objectives.
A high standard of excellence in governance and accountability has been instilled within Pharmed culture.